CLOVIS ONCOLOGY INC's ticker is CLVS and the CUSIP is 189464100. A total of 175 filers reported holding CLOVIS ONCOLOGY INC in Q3 2020. The put-call ratio across all filers is 0.94 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $21,000 | 0.0% | 10,500 | 0.0% | 0.03% | +100.0% |
| Q1 2022 | $21,000 | -80.9% | 10,500 | -58.1% | 0.01% | -53.3% |
| Q4 2021 | $110,000 | +8.9% | 25,070 | +9.0% | 0.03% | +3.4% |
| Q3 2021 | $101,000 | -22.3% | 23,000 | -3.2% | 0.03% | -45.3% |
| Q2 2021 | $130,000 | -16.1% | 23,750 | 0.0% | 0.05% | +10.4% |
| Q1 2021 | $155,000 | +36.0% | 23,750 | 0.0% | 0.05% | -2.0% |
| Q4 2020 | $114,000 | -19.1% | 23,750 | -2.1% | 0.05% | -22.2% |
| Q3 2020 | $141,000 | -13.0% | 24,250 | +0.8% | 0.06% | -7.4% |
| Q2 2020 | $162,000 | +36.1% | 24,050 | +29.6% | 0.07% | +28.3% |
| Q1 2020 | $119,000 | +4.4% | 18,550 | +67.9% | 0.05% | +26.2% |
| Q4 2019 | $114,000 | – | 11,050 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Palo Alto Investors LP | 3,402,781 | $231,389,000 | 9.96% |
| Versant Venture Management, LLC | 101,855 | $6,926,140,000 | 7.29% |
| Avoro Capital Advisors LLC | 1,102,884 | $74,996,000 | 4.86% |
| Redmile Group, LLC | 1,320,027 | $89,762,000 | 3.90% |
| NEXTHERA CAPITAL LP | 233,200 | $15,858,000 | 2.92% |
| Iguana Healthcare Management, LLC | 60,000 | $4,080,000 | 2.66% |
| HealthCor Management, L.P. | 973,840 | $66,221,000 | 2.16% |
| Casdin Capital, LLC | 127,500 | $8,670,000 | 2.11% |
| Prosight Management, LP | 40,000 | $2,720,000 | 2.00% |
| Camber Capital Management LP | 600,000 | $40,800,000 | 2.00% |